Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke "ICAS"


Phase 3 Results N/A

Summary of Purpose

Hyperglycemia is common during acute ischemic stroke. However, the optimal strategy to control hyperglycemia during acute ischemic stroke has not been established. The object of this multicenter randomized controlled study is to determine the efficacy and safety of early initiation of subcutaneous once-daily insulin glargine, in comparison with regular insulin, based on a protocolized sliding scale regimen to...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 August 2016.

1 Dec 2015 4 Nov 2015 1 Jul 2018 1 Nov 2018 1 Aug 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment